Canada Drugs Direct

Visiting from Canada?

Want to save up to 80% on your medications? Signup below to be notified if we open a Canadian Online Pharmacy.

I agree to receive email updates from Canada Drugs Direct

Looking for CanadaDrugsDirect.net? Call us toll free 1-800-500-2897

Fulphila (Pegfilgrastim)

Prescription medicineOnly Available By Prescription

What if I find a lower price with another pharmacy?

We guarantee the lowest price on all of our prescription products. If you find your medications cheaper at any other recognized licensed mail order pharmacy, we will not only match their price, we will beat it by 25% of the difference. It is our 125% price match guarantee!

Example: If you find a product on Canada Drugs Direct for $50.00 and find the same product for $40.00 at another mail order pharmacy, we will provide you with a $12.50 discount, bringing your total to $37.50.

To get the discount please make sure to mention the price match to the customer service team when they call to collect payment for your order. Or call toll free at 1-888-904-8467 to place the order through the phone.

Terms & Conditions of Program

  • Guaranteed lowest price is only valid at the time of sale.
  • We will only match the current advertised price.
  • Products must be identical and in stock at the time of placing an order with a licensed mail order pharmacy. The must be a member of CIPA (Canadian International Pharmacy Association).
  • Products must be authentic in brand and size (same manufacturer, same country of manufacture, same pack size, same strength and same quantity).
  • Products must be new. We cannot match the price of any used, short expiry or expired product.
  • Price match can only be issued over the phone with our customer service team
What is a Generic Drug?

A generic drug is a copy of the brand-name drug with the same dosage, safety, strength, quality, consumption method, performance, and intended use. Before generics become available on the market, the generic company must prove it has the same active ingredients as the brand-name drug and works in the same way and in the same amount of time in the body.

The only differences between generics and their brand-name counterparts is that generics are less expensive and may look slightly different (eg. different shape or color), as trademarks laws prevent a generic from looking exactly like the brand-name drug.

Generics are less expensive because generic manufacturers don't have to invest large sums of money to develop a drug. When the brand-name patent expires, generic companies can manufacture a copy of the brand-name and sell it at a substantial discount.

Description

Your doctor or oncologist may prescribe Fulphila if you have a non-myeloid malignancy, are receiving chemotherapy to suppress the immune system, and have clinically significant febrile neutropenia. Febrile neutropenia is when white blood cells are low, and there is a fever. These symptoms indicate that the person has an infection but their immune system is not strong enough to fight it.

Fulphila contains pegfilgrastim, which is a pegylated form of naturally occurring granulocyte colony-stimulating factors (G-CSF). Fulphilka binds to bone marrow cells, augmenting their growth and replication. Binding to bone marrow cells leads to an increase in neutrophils, fortifying the body's defense against infections and restoring immune system function.

Directions

The recommended dosage of Fulphila is 6 mg administered as a single subcutaneous injection per chemotherapy cycle. The timing and frequency may vary based on the specific chemotherapy regimen and individual patient characteristics.

Do not stop or change your treatment without speaking to your oncologist.

Ingredients

The active ingredient in Fulphila is pegfilgrastim.

Interactions

  • Fulphiila has no known drug-drug interactions

Cautions

White blood cells should be closely monitored while taking this drug.

Stop Fulphila if breathing\ trouble occurs, because it could mean a hypersensitivity reaction or acute respiratory distress syndrome (ARDS).

Patients with a personal or family history of sickle cell disease or kidney disease should inform their doctors before starting this medication.

Fulphila should not be administered 14 days before or 24 hours after cytotoxic chemotherapy.

Pediatric patients receive a weight-based dose.

Immediate medical attention is needed for symptoms such as left upper abdominal or shoulder pain, indicative of a potential enlarged spleen or splenic rupture.

Side Effects

Common adverse reactions to this drug may include:

  • Acute myeloid leukemia
  • Acute respiratory distress syndrome
  • Aortitis
  • Anaphylaxis
  • Bone pain
  • Capillary leak syndrome
  • Glomerulonephritis
  • Leukocytosis
  • Myelodysplastic syndrome
  • Pain in limb
  • Rupture of spleen
  • Sickle cell anemia with crisis
  • Thrombocytopenia

References

Fulphila [package insert]. Zurich, Switzerland: Mylan; June 2018.



IMPORTANT NOTE: The above information is intended to increase awareness of health information and does not suggest treatment or diagnosis. This information is not a substitute for individual medical attention and should not be construed to indicate that use of the drug is safe, appropriate, or effective for you. See your health care professional for medical advice and treatment.

product reviews icon Product Reviews